If you are not completely satisfied with your order, for any reason, simply contact us to receive a full and immediate refund. No questions asked – and we pay return shipping.
Need Assistance? Give us a call! 1-800-249-5770 -or- e-mail us
All purchases are covered by EB Medicine's 100% money-back guarantee.
If you are not completely satisfied with your order, for any reason, simply contact us to receive a full and immediate refund. No questions asked - and we pay return shipping.
Home > EB Store > Diagnosis And Management Of Skin And Soft Tissue Infections In Children
Diagnosis And Management Of Skin And Soft Tissue Infections In Children - $30.00
This issue includes 4 AMA/ACEP category 1, AAP Prescribed CME credits
Authors:
Neil G. Uspal, MD and
Dewesh Agrawal, MD
Peer Reviewers:
Denis Pauze, MD, FACEP and
Michael Witt, MD, MPH, FAAP
Publication Date:
February 1, 2008, Volume 5, Number 2
Excerpt from the issue…
It’s a typical busy ED afternoon, and the waiting room is full. Your first patient is a two-year-old boy presenting with “bug bites.” As you greet the patient’s mother, she tells you that she never should have bought a home so close to the water, because she doesn’t remember her oldest son getting as many bug bites as the child with her today. You take the history and are surprised to learn that the bites are in the patient’s diaper area. After removing the child’s diaper, you realize that instead of bug bites he has three areas of cellulitis, one of which appears fluctuant. You begin to consider what the likelihood is that this child has contracted an infection with methicillin-resistant Staphylococcus aureus and how you should best treat it if that is what it is.
About this article:
Skin and soft tissue infections are one of the most common reasons for children to present to the emergency department (ED). In one study, the authors estimated that over 11 million ambulatory healthcare visits occur each year for skin and soft tissue infections due to Staphylococcus aureus (S. aureus) alone.1 Yet these infections have also become some of the most difficult conditions to treat. This is due to new, rapidly emerging patterns of resistance. When penicillin was first developed in 1941, all S. aureus isolates were sensitive to it.2 Today, however, S. aureus is virtually uniformly resistant to penicillin, and the majority of community-associated staphylococcal infections are becoming resistant to the semisynthetic penicillins as well. This new wave of community-acquired methicillin-resistant S. aureus (CAMRSA) is rapidly making obsolete many of the pharmacologic strategies ED physicians have been using for these infections. Additionally, other mutations in the DNA of S. aureus have made it much more virulent than before. Infections have become more aggressive, often requiring invasive treatment.
This issue of Pediatric Emergency Medicine Practice will focus on the management of children with skin and soft tissue infections based on the newest and best available evidence from the literature. This issue will also review some of the more unusual presentations and pathogens involved in skin and soft tissue infections and the best ways to treat them.
